Publications
87
Citations
701
Est. group size
~2
Recurring co-author estimate
Active years
19
Publishing since 2008
Roberto Borea's work focuses on clinical and translational oncology, particularly breast and lung cancer, including studies on endocrine therapy, molecular and genomic tumor analysis, and liquid biopsy (a blood-based method for detecting cancer-related molecular changes without invasive tissue sampling). He also contributes to large-scale cancer epidemiology efforts, such as global and regional cancer incidence and mortality reporting.
Publication output has grown substantially over the last decade, rising from occasional single papers per year before 2020 to over 20 publications annually in 2025 and 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies
European Journal of Cancer · 2026
- Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trials
ESMO Open · 2026
- Abstract 2307: Body mass index-associated transcriptomic signatures reveal immune, stromal, and metabolic rewiring in non-small cell lung cancer: Insights into the obesity paradox
Cancer Research · 2026
- Abstract 4577: Targeting midkine-driven oncogenic signaling with HBS-101: A novel therapeutic strategy for lung cancer
Cancer Research · 2026
- Cancer in a Drop: Liquid biopsy insights from ESMO 2025
The Journal of Liquid Biopsy · 2026
- Advances in early-stage lung cancer patients: from preanalytics to molecular analysis
Critical Reviews in Oncology/Hematology · 2026
- Supplementary Figure S4 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Table S4 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Figure S2 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Table 1 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Figure S7 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Figure 1 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Figure S3 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Table S6 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- Supplementary Table S5 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
2026
- The Journal of Liquid Biopsy×9
- Annals of Oncology×6
- Cancers×5
- ESMO Open×5
- Critical Reviews in Oncology/Hematology×3
- Rachel J. Meadows
Medicine · The Ohio State University
- Karen Patricia Williams
Medicine · The Ohio State University
- Anna Muraveva
Medicine · The Ohio State University
- Nicholas Pettit
Medicine · Indiana University
- JC Chen
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile